Rajiv Gandhi University of Health Sciences

; A. Sarpatwari). “The status quo increasingly threatens public health, as rising drug prices present growing access challenges for patients and indication slicing hampers collection of critical preapproval information on the safety and efficacy of drugs when used in ways that will reflect their most common use in the market. ................
................